BioXcel Therapeutics, Inc. (BTAI) Net margin 2022–2025
BioXcel Therapeutics, Inc. (BTAI) net profit margin by fiscal year — reported net income divided by reported revenue.
-10887.4%FY2025 · since FY2022: -44201.9% → -10887.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -10887.4% | -8257.2 pp |
| FY2024 | -2630.1% | +10344.7 pp |
| FY2023 | -12974.9% | +31227.0 pp |
| FY2022 | -44201.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice